Breast cancer survival and treatment in health maintenance organization and fee-for-service settings

Journal of the National Cancer Institute

Volumn 89, Issue 22, 1997, Pages 1683-1691

  Potosky, Arnold L ^a,e   Merrill, Ray M ^a   Riley, Gerald F ^b   Taplin, Stephen H ^c   Barlow, William ^c   Fireman, Bruce H ^d   Ballard Barbash, Rachel ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CENTERS FOR MEDICARE AND MEDICAID SERVICES   (United States)

^c CENTER FOR HEALTH STUDIES   (United States)

^d DIVISION OF RESEARCH   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEALTH MAINTENANCE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL FEE; PARTIAL MASTECTOMY; UNITED STATES;

EID: 0030669414     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.22.1683     Document Type: Article

References (47)

1. Kosary CL, Ries LA, Miller BA, Hankey BF, Harras A, Edwards BK, editors. SEER Cancer Statistics Review, 1973-1992: tables and graphs, National Cancer Institute. NIH Publ No. 96-2789. Bethesda (MD), 1995.
2. Lee-Feldstein A, Anton-Culver H, Feldstein PJ. Treatment differences and other prognostic factors related to breast cancer survival. Delivery systems and medical outcomes. JAMA 1994;271:1163-8.
3. National Center for Health Statistics. Health, United States, 1996-97 and Injury Chartbook Sec K. Hyattsville (MD): Centers for Disease Control and Prevention, Department of Health and Human Services, 1997.
4. Manning WG, Leibowitz A, Goldberg GA, Rogers WH. Newhouse JP. A controlled trial of the effect of a prepaid group practice on use of services. N Engl J Med 1984;310:1505-10.
5. Miller RH, Luft H,. Managed care plan performance since 1980. A literature analysis. JAMA 1994;271:1512-9.
6. Sloss EM, Keeler EB, Brook RH, Operskalski BH, Goldberg GA. New-house JP. Effect of a health maintenance organization on physiologic health. Results from a randomized trial. Ann Intern Med 1987;106:130-8.
7. Clancy CM, Brody H. Managed care. Jekyll or Hyde? [editorial] JAMA 1995;273:338-9.
8. Kassirer JP. The new health care game. N Engl J Med 1996;335:433.
9. Brook RH, Kamberg CJ, McGlynn EA. Health system reform and quality. JAMA 1996;276:476-80.
10. Elwood PM Jr, Lundberg GD. Managed care: a work in progress. JAMA 1996;276:1083-6.
11. Greenfield S, Rogers W, Mangotich M, Carney MF, Tarlov AR. Outcomes of patients with hypertension and non-insulin dependent diabetes mellitus treated by different systems and specialties. Results from the Medical Outcomes Study. JAMA 1995;274:1436-44.
12. Ware JE Jr, Bayliss MS, Rogers WH, Kosinski M, Tarlov AR. Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and fee-for-service systems. Results from the Medical Outcomes Study. JAMA 1996;276:1039-17.
13. Clement DG, Retchin SM, Brown RS, Stegall MH. Access and outcomes of elderly patients enrolled in managed care [published erratum appears in JAMA 1994;272:276]. JAMA 1994;271:1487-92.
14. Brown RS, Bergeron JW, Clement DG, Hill JW, Retchin SM. The Medicare risk program for HMOs - final summary report on findings from the evaluation. Final report under HCFA contract Number 500-8-0006. Princeton (NJ): Mathematica Policy Research, Inc., 1993.
15. American Joint Committee on Cancer. Manual for staging of cancer. Philadelphia: Lippincott, 1992.
16. Potosky AL, Riley , GF, Lubitz JD, Mentnech RM, Kessler LG. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 1993;31:732-48.
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
18. Deyo RA, Gherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45: 613-9.
19. Rasell ME. Cost sharing in health insurance - a reexamination [editorial]. N Engl J Med 1995;332:1164-8.
20. Short PF, Lair TJ. Health insurance and health status: implications for financing health care reform. Inquiry 1994;31:425-37.
21. Greenwald HP, Henke CJ. HMO membership, treatment, and mortality risk among prostatic cancer patients. Am J Public Health 1992;82: 1099-104.
22. Retchin SM, Brown B. Management of colorectal cancer in Medicare health maintenance organizations. J Gen Intern Med 1990;5:110-4.
23. Retchin SM, Brown B. The quality of ambulatory care in Medicare health maintenance organizations. Am J Public Health 1990;80:411-5.
24. Makuc DM, Freid VM, Parsons PE. Health insurance and cancer screening among women. NCHS Adv Data 1994;254:1-11.
25. Greenwald HP. Who survives cancer? Berkeley, CA: University of California Press, 1992.
26. Eley JW, Hill HA, Chen VW, Austin DF, Wesley MN, Muss HB, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA 1994;272: 947-54.
27. Shapiro S, Venet W, Strax P, Venet L. Periodic screening for breast cancer: The Health Insurance Plan project and its sequelae, 1963-1986. Baltimore: The Johns Hopkins University Press, 1988.
28. Tabar L, Fagerberg CJ, Gad A, Baldetorp L, Holmberg LH, Grontoft O, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985;1:829-32.
29. Connor RJ, Chu KC, Smart CR. Stage-shift cancer screening model. J Clin Epidemiol 1989;42:1083-95.
30. Prorok PC, Connor RJ, Baker SG. Statistical considerations in cancer screening programs. Urol Clin North Am 1990;17:699-708.
31. Prevention and managed care: opportunities for managed care organizations, purchasers of health care, and public health agencies. MMWR Morb Mortal Wkly Rep 1995;44:1-12.
32. Trock B, Rimer BK, King E, Balshem A, Cristinzio CS, Engstrom PF. Impact of an HMO-based intervention to increase mammography utilization. Cancer Epidemiol Biomarkers Prev 1993;2:151-6.
33. Carter AP, Thompson RS, Bourdeau RV, Andenes J, Mustin H, Straley H. A clinically effective breast cancer screening program can be cost-effective, too. Prev Med 1987;16:19-34.
34. Thompson RS, Barlow WE, Taplin SH, Grothaus L,. Immanuel V, Salazar A, et al. A population-based case-cohort evaluation of the efficacy of mammographic screening for breast cancer. Am J Epidemiol 1994;140: 889-901.
35. Riley GF, Potosky AL, Lubitz JD, Brown ML. Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees. Am J Public Health 1994; 84:1598-604.
36. Campbell KM, Holm K. Preventive service utilization among older women: a comparison of HMO members, private insurance policy holders, and Medicare recipients. Olympia (WA): Washington State Department of Health, Center for Health Statistics, 1995.
37. Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerham L, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer [published erratum appears in N Engl J Med 1994;330:1467]. N Engl J Med 1989;320:822-8.
38. Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch P, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. J Natl Cancer Inst 1996;88:1659-64.
39. Veronesi U, Luini A, Del Vecchio M, Greco M, Galimberti V, Merson M, et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 1993;328:1587-91.
40. NIH consensus conference. Treatment of early-stage breast cancer. JAMA 1991;265:391-5.
41. Baue AE. Breast-conservation operations for treatment of cancer of the breast [editorial]. JAMA 1994;271:1204-5.
42. Riley G, Tudor C, Chiang YP, Ingber M. Health status of Medicare enrollees in HMOs and fee-for-service in 1994. Health Care Financ Rev 1996;17:65-76.
43. Retchin SM, Clement DG, Rossiter LF, Brown B, Broun R, Nelson L. How the elderly fare in HMOs: outcomes from the Medicare competition demonstrations. Health Serv Res 1992;27:651-69.
44. Pappas G, Queen S, Hadden W, Fisher G. The increasing disparity in mortality between socioeconomic groups in the United States. 1960 and 1986 [published erratum appears in N Engl J Med 1993;329:1139]. N Engl J Med 1993;329:103-9.
45. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 1992;82:703-10.
46. Dayal HH, Power RN, Chiu C. Race and socio-economic status in survival from breast cancer. J Chronic Dis 1982;35:675-83.
47. Greenwald HP, Polissar NL, Borgatta EF, McCorkle R. Detecting survival effects of socioeconomic status: problems in the use of aggregate measures. J Clin Epidemiol 1994;47:903-9.